.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
McKinsey
Cantor Fitzgerald
Deloitte
AstraZeneca
Medtronic
Fish and Richardson
Citi
Harvard Business School
McKesson

Generated: December 13, 2017

DrugPatentWatch Database Preview

Patents Expiring in July 2017

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Janssen PharmsCONCERTAmethylphenidate hydrochlorideTABLET, EXTENDED RELEASE;ORAL021121-004Apr 1, 2002ABRXYesNo► Subscribe► Subscribe► SubscribeFOR CLAIMS 1-4,6-14,16-24 AND 26-32: METHOD OF TREATING ADHD IN CHILDREN 6 YEARS OF AGE AND OLDER AND ADOLESCENTS
Janssen PharmsCONCERTAmethylphenidate hydrochlorideTABLET, EXTENDED RELEASE;ORAL021121-004Apr 1, 2002ABRXYesNo► Subscribe► Subscribe► SubscribeFOR CLAIMS 1-3,6-13,16-24AND 26-32: METHOD OF TREATING ADHD
Janssen PharmsCONCERTAmethylphenidate hydrochlorideTABLET, EXTENDED RELEASE;ORAL021121-002Aug 1, 2000ABRXYesNo► Subscribe► Subscribe► SubscribeYMETHOD OF TREATING ADHD
Janssen PharmsCONCERTAmethylphenidate hydrochlorideTABLET, EXTENDED RELEASE;ORAL021121-002Aug 1, 2000ABRXYesNo► Subscribe► Subscribe► SubscribeFOR CLAIMS 1-4,6-14,16-24 AND 26-32: METHOD OF TREATING ADHD IN CHILDREN 6 YEARS OF AGE AND OLDER AND ADOLESCENTS
Janssen PharmsCONCERTAmethylphenidate hydrochlorideTABLET, EXTENDED RELEASE;ORAL021121-002Aug 1, 2000ABRXYesNo► Subscribe► Subscribe► SubscribeFOR CLAIMS 1-3,6-13,16-24AND 26-32: METHOD OF TREATING ADHD
Janssen PharmsCONCERTAmethylphenidate hydrochlorideTABLET, EXTENDED RELEASE;ORAL021121-001Aug 1, 2000ABRXYesNo► Subscribe► Subscribe► SubscribeYMETHOD OF TREATING ADHD
Janssen PharmsCONCERTAmethylphenidate hydrochlorideTABLET, EXTENDED RELEASE;ORAL021121-003Dec 8, 2000ABRXYesYes► Subscribe► Subscribe► SubscribeYMETHOD OF TREATING ADHD
Janssen PharmsCONCERTAmethylphenidate hydrochlorideTABLET, EXTENDED RELEASE;ORAL021121-001Aug 1, 2000ABRXYesNo► Subscribe► Subscribe► SubscribeFOR CLAIMS 1-3,6-13,16-24AND 26-32: METHOD OF TREATING ADHD
Janssen PharmsCONCERTAmethylphenidate hydrochlorideTABLET, EXTENDED RELEASE;ORAL021121-003Dec 8, 2000ABRXYesYes► Subscribe► Subscribe► SubscribeFOR CLAIMS 1-3,6-13,16-24AND 26-32: METHOD OF TREATING ADHD
Janssen PharmsCONCERTAmethylphenidate hydrochlorideTABLET, EXTENDED RELEASE;ORAL021121-001Aug 1, 2000ABRXYesNo► Subscribe► Subscribe► SubscribeFOR CLAIMS 1-4,6-14,16-24 AND 26-32: METHOD OF TREATING ADHD IN CHILDREN 6 YEARS OF AGE AND OLDER AND ADOLESCENTS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Citi
McKinsey
UBS
QuintilesIMS
Colorcon
Harvard Business School
Chubb
Julphar
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot